Literature DB >> 33168114

Expertise, experience, and excellence. Twenty years of patient involvement in health technology assessment at NICE: an evolving story.

Laura Norburn1, Lizzie Thomas1.   

Abstract

From its inception in 1999, the National Institute for Health and Care Excellence (NICE) committed to including the expertise, experiences, and perspectives of lay people, patients and carers, and patient organizations in its health technology assessments (HTAs). This is our story of patient involvement in HTA: from early methods designed for use when assessing medicines, widening to address the different requirements of HTAs for interventional procedures, medical technologies, and diagnostic technologies. We also chart the evolution and development of all our patient involvement methods over the past 20 years through regular evaluation and by responding to external challenge. However, we know that processes and methods alone are not enough. Through case studies we demonstrate the value of patient involvement in HTA and highlight the unique perspectives and experiences that patients bring to HTA committees. Finally, we discuss the underpinning principles and commitments that have made NICE a world leader in delivering meaningful and legitimate patient involvement.

Entities:  

Keywords:  Biomedical; Decision making; England; Health care economics and organizations; Patient participation; Technology assessment

Year:  2020        PMID: 33168114     DOI: 10.1017/S0266462320000860

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  4 in total

1.  Patients and public are important stakeholders in health technology assessment but the level of involvement is low - a call to action.

Authors:  Janet L Wale; Samuel Thomas; Dominique Hamerlijnck; Ronald Hollander
Journal:  Res Involv Engagem       Date:  2021-01-05

Review 2.  Reinforcing Collaboration and Harmonization to Unlock the Potentials of Advanced Therapy Medical Products: Future Efforts Are Awaited From Manufacturers and Decision-Makers.

Authors:  Tingting Qiu; Shuyao Liang; Yitong Wang; Claude Dussart; Borislav Borissov; Mondher Toumi
Journal:  Front Public Health       Date:  2021-11-25

3.  Can We Afford to Exclude Patients Throughout Health Technology Assessment?

Authors:  Janet L Wale; David Chandler; Deborah Collyar; Dominique Hamerlijnck; Roberto Saldana; Zack Pemberton-Whitely
Journal:  Front Med Technol       Date:  2022-01-25

4.  Innovative Patient Involvement During Covid-19: Keeping Patients at the Heart of HTA.

Authors:  Mark Rasburn; Helen Crosbie; Amanda Tonkinson; David Chandler; Tasneem Dhanji; Stephen Habgood; Stella O'Brien
Journal:  Front Med Technol       Date:  2021-12-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.